The Post-Partisan Emporium

  ‘Expresso Vaccines’ and Lessons from the American Chestnut Tree Why a vaccine designed in two days faced less regulatory scrutiny than a venerable nut tree that sustained life for centuries Dr. Mathew Maavak A tree that once fed multitudes now faces a decade of federal red tape before a single seed can touch wild soil, while a brand-new genetic vaccine, cooked up in 48 hours and injected into billions, sailed through approval in under a year. One restores a vanished forest, the other rewrote human cells on a planetary scale. Both are genetic modifications, yet one is treated as a potential ecological threat while the other is hailed as a modern miracle. Welcome to the “expresso lane” of modern biotechnology, where speed, risk, and scrutiny depend entirely on whose veins are on the line. Reign of the Chestnut King In the ancient forests of Appalachia, the American Chestnut (Castanea dentata) once towered as the unmatched monarch. Stretching from the southern ridges to southern Can...

  Cold Harbor: Eugenics, Epstein and Big Tech In the recent cache of Jeffrey Epstein emails unveiled by Bloomberg, Epstein’s connections to the elites of academia illuminate his interest in transhumanism, or neo-eugenics — a philosophy that has become commonplace among Big Tech oligarchs and ruling class elites. Shaping the development of pharmaceutical products, inspiring emergency-based deregulation and dovetailing with the expansion of the biomedical surveillance state, the material implications of this belief system are consequential and widespread. by Max Jones November 6, 2025 23 minute read Within the trove of the notorious Jeffrey Epstein’s emails recently acquired by  Bloomberg , the late pedophile and ruling class socialite proposed to fund an interesting program –– Harvard’s Personal Genome Project (PGP). Epstein’s reason for doing so? To find out if “beauty resides in DNA.” This anecdote, along with a few others in  Bloomberg ’s first  exposé  into t...